Prostate Cancer
A comparison of prostate health index, total PSA, %free PSA, and proPSA in a contemporary US population-The MiCheck-01 prospective trial.
November 21, 2023
Prostate Cancer Local Staging with Magnetic Resonance Imaging.
November 20, 2023
Phase 1b study of enzalutamide plus CC-115, a dual mTORC1/2 and DNA-PK inhibitor, in men with metastatic castration-resistant prostate cancer (mCRPC).
November 20, 2023
A Practical Guide to the Pearls and Pitfalls of PSMA PET Imaging.
November 20, 2023
Pfizer and Astellas' XTANDI® Approved by U.S. FDA in Earlier Prostate Cancer Treatment Setting
November 17, 2023
Prostate Cancer, Race, and Health Disparity: What We Know.
November 17, 2023
Clinical-Genomic Risk Group Classification of Suspicious Lesions on Prostate Multiparametric-MRI.
November 16, 2023
Olaparib for the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer and Alterations in BRCA1 and/or BRCA2 in the PROfound Trial.
November 16, 2023
PROMISE Registry: A prostate cancer registry of outcomes and germline mutations for improved survival and treatment effectiveness.
November 16, 2023
Access to Care and Healthcare Quality Metrics for Patients with Advanced Genitourinary Cancers in Urban versus Rural Areas.
November 15, 2023